otonomy
report
third
quarter
financial
results
provide
corporate
update
san
diego
globe
newswire
otonomy
nasdaq
otic
biopharmaceutical
company
dedicated
development
innovative
therapeutics
neurotology
today
announced
report
financial
results
third
quarter
provide
corporate
update
et
november
live
call
may
accessed
dialing
domestic
callers
international
callers
conference
id
code
number
live
webcast
call
available
online
investor
relations
section
otonomy
website
archived
days
otonomy
otonomy
biopharmaceutical
company
dedicated
development
innovative
therapeutics
neurotology
company
pioneered
application
drug
delivery
technology
ear
order
develop
products
achieve
sustained
drug
exposure
single
local
administration
approach
covered
broad
patent
estate
utilized
develop
pipeline
products
addressing
important
unmet
medical
needs
including
ménière
disease
hearing
loss
tinnitus
additional
information
please
visit
contacts
media
inquiries
spectrum
science
ramsey
vice
president
cramsey
investor
inquiries
westwicke
icr
robert
uhl
managing
director
